Suspected Vaccine-Associated Hypophysitis With Central Diabetes Insipidus After AZD1222 SARS-CoV-2 Vaccination.
作者信息
Soll Dominik, Heinz Rebecca, Mai Knut
出版信息
Dtsch Arztebl Int. 2024 Jun 14;121(12):414. doi: 10.3238/arztebl.m2023.0106.
Abstract
摘要
相似文献
1
Suspected Vaccine-Associated Hypophysitis With Central Diabetes Insipidus After AZD1222 SARS-CoV-2 Vaccination.接种AZD1222型新冠疫苗后疑似疫苗相关垂体炎伴中枢性尿崩症
Dtsch Arztebl Int. 2024 Jun 14;121(12):414. doi: 10.3238/arztebl.m2023.0106.
2
Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?中枢性尿崩症：BNT162b2 新冠病毒 mRNA 疫苗的迟发后遗症？
BMC Endocr Disord. 2023 Feb 22;23(1):47. doi: 10.1186/s12902-023-01296-4.
3
AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.抗 COVID-19 BNT162b2 Comirnaty 疫苗接种后青少年发生 AVP 缺乏症（中枢性尿崩症）：1 例报告。
Front Endocrinol (Lausanne). 2023 Apr 18;14:1166953. doi: 10.3389/fendo.2023.1166953. eCollection 2023.
4
A case of hypophysitis after COVID-19 vaccination with a detection of anti-pituitary antibody, with review of literature.接种 COVID-19 疫苗后发生垂体炎，伴有垂体抗体检测，文献复习。
Endocr J. 2024 Aug 8;71(8):799-807. doi: 10.1507/endocrj.EJ24-0061. Epub 2024 May 3.
5
Bilateral Optic Neuritis and Hypophysitis With Diabetes Insipidus 1 Month After COVID-19 mRNA Vaccine: Case Report and Literature Review.新冠病毒 mRNA 疫苗接种后 1 个月发生双侧视神经炎和垂体炎伴尿崩症：病例报告及文献复习。
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231186046. doi: 10.1177/23247096231186046.
6
Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.中枢性尿崩症（垂体柄神经垂体炎）：新型冠状病毒肺炎感染的晚期并发症。
J Endocrinol Invest. 2021 Dec;44(12):2855-2856. doi: 10.1007/s40618-021-01627-z. Epub 2021 Jul 3.
7
Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report.接种 BNT162b2 mRNA COVID-19 疫苗后发生中枢性尿崩症：病例报告。
Front Endocrinol (Lausanne). 2022 May 4;13:889074. doi: 10.3389/fendo.2022.889074. eCollection 2022.
8
A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine.接种 mRNA-1273 型 SARS-CoV-2 疫苗后发生的垂体炎病例报告。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211043386. doi: 10.1177/23247096211043386.
9
Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.抗程序性细胞死亡蛋白 1 主动免疫治疗相关中枢性尿崩症。
Int Immunopharmacol. 2020 Jun;83:106427. doi: 10.1016/j.intimp.2020.106427. Epub 2020 Mar 31.
10
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.β 变异株 COVID-19 疫苗 AZD2816 和 AZD1222（ChAdOx1 nCoV-19）作为初免接种程序在巴西、南非、波兰和英国的未曾接种过疫苗的成年人中的免疫原性和安全性：一项随机、部分双盲、2/3 期非劣效免疫桥接研究。
Lancet Microbe. 2024 Aug;5(8):100863. doi: 10.1016/S2666-5247(24)00078-8. Epub 2024 Jun 12.
Zotero 插件